Monrol Nuclear Products Inc. has commenced its nuclear medicine business by importing radiopharmaceuticals. 
  The production trials for the first domestic 99Mo/99mTc generator were initiated with the cooperation of TAEK-ÇNAEM (Çekmece Nuclear Research and Training Center of the Turkish Atomic Energy Agency).
  The production of 99Mo/99mTc generator was initiated in ÇNAEM and presented to Turkish nuclear medicine market.
  The production of F18 FDG (Florodeoxy-D-glucose), PET and SPECT products were initiated in the plant located in TUBITAK Technopark / Gebze.
  Licenses received from TAEA for Radiation Safety and the Ministry of Health for complying with Good Manufacturing Practices (GMP).
Licences received for ISO 9001:2000 Quality Management and ISO 14001 Environment Management.
  Expansion of the product range; the GMP licence renewed for the radiopharmaceutical kit production.
  Production was initiated in Ankara Plant.
  Production was initiated in Adana Plant.
  Monrol Nuclear Products Inc. and Eczacıbaşı Pharmaceuticals Manufacturings have become a 50:50 joint venture. Regarding this agreement Monrol Nuclear Products Inc. which is manufacturing, importing,distributing radiopharmaceuticals used in nuclear medicine, was named Eczacıbaşı-Monrol Nuclear Products Co.
Authorization procedure of MON-IODINE (I-131) and MON-TEK Generators was started for EU countries.
  Production was initiated in İzmir Plant.
  Production was initiated in İstanbul Plant.
EU GMP registration completed.
A new PET pharmaceutic Na18F which is used for bone imaging, was launched and production process started.
In August 2011, Eczacıbaşı Monrol has added a value its value chain by acquisition of Mol Image company. Molecular Imaging Industry and Trading Co. Inc.(Mol Image), was established in 2002 as a R&D and hi-tech company, aims to make research, development, innovation and production in the field of Molecular Medicine and become one of the leading companies in Turkey.
Production was initiated in Antalya Plant.
  Production were initiated in Bucharest and Malatya Plants.
Capintec, the world’s best known brand in the field of radiation measurement and protection products for nuclear medicine acquired.
  Shares of Cairo Cyclotron Plant were taken over
Production was initiated in Poland Plant.